The need for more effective lung cancer treatments is paramount, as the disease remains a leading cause of cancer deaths in ...

Validation studies are expected to conclude by the end of 2026, with potential integration into the NSCLC clinical programme ...

Researchers compared survival outcomes in patients with non-small cell lung cancer who underwent surgical resection vs radiotherapy.

HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...

Data from the COMPEL trial support extending osimertinib (Tagrisso, AstraZeneca) therapy to patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who progress on first-line treatment ...

GSK plc GSK announced that the FDA has approved Jideytro (zidesamtinib) for previously treated ROS1-positive non-small cell ...

BlossomHill Therapeutics, Inc. (BLSM) has filed proposed terms for its $125 million IPO, according to an amended S-1/A registration statement. The company is a clinical-stage biopharma developing ...

Your treatment journey for non-small-cell lung cancer (NSCLC) may vary from that of others with the same diagnosis. But you’ll likely start with some of the same treatments. You’ll have lots of ...

A diagnosis of non-small cell lung cancer (NSCLC) can significantly affect emotional health, leading to mental health challenges such as depression, anxiety, and distress. Comprehensive mental health ...

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that new analyses of long-term Phase 2 TRUST-I and ...